ODI Pharma AB (publ) (NGM:ODI)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.210
+0.010 (0.83%)
At close: Nov 5, 2025
0.83%
Market Cap25.48M
Revenue (ttm)3.11M
Net Income (ttm)-5.88M
Shares Out18.33M
EPS (ttm)-0.32
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume600
Average Volume2,693
Open1.210
Previous Close1.200
Day's Range1.210 - 1.210
52-Week Range1.200 - 4.000
Beta0.42
RSI50.65
Earnings DateNov 27, 2025

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In 2025, ODI Pharma AB's revenue was 3.11 million, a decrease of -86.04% compared to the previous year's 22.29 million. Losses were -5.88 million, 934.9% more than in 2024.

Financial Statements

News

There is no news available yet.